| scholarly article | Q13442814 |
| P50 | author | Ann Arvin | Q4766238 |
| Jeremy O Jones | Q78720330 | ||
| P2860 | cites work | A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB | Q24321775 |
| The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase | Q24561643 | ||
| The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes | Q24607496 | ||
| NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses | Q27861101 | ||
| Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins | Q28145950 | ||
| The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination | Q28201717 | ||
| Oscillations in NF-kappaB signaling control the dynamics of gene expression | Q28289121 | ||
| Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway | Q28615591 | ||
| The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation | Q29617813 | ||
| Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo | Q30531746 | ||
| Herpes simplex virus ICP0 mutants are hypersensitive to interferon | Q33798242 | ||
| Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. | Q34131747 | ||
| Varicella-zoster virus (VZV) ORF17 protein induces RNA cleavage and is critical for replication of VZV at 37 degrees C but not 33 degrees C. | Q34349183 | ||
| mRNA degradation by the virion host shutoff (Vhs) protein of herpes simplex virus: genetic and biochemical evidence that Vhs is a nuclease | Q34362360 | ||
| Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region | Q34434911 | ||
| Activation and inhibition of virus and interferon: the herpesvirus story | Q34600005 | ||
| Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6. | Q34789652 | ||
| Nf-kappa B, chemokine gene transcription and tumour growth | Q34810265 | ||
| Ubiquitin: not just for proteasomes anymore | Q35089381 | ||
| Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). | Q35319917 | ||
| Regulation of JAK-STAT signalling in the immune system | Q35605437 | ||
| Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology | Q35815962 | ||
| Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice | Q35845405 | ||
| Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters | Q35845633 | ||
| The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA- | Q35964369 | ||
| Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection | Q36090467 | ||
| Activation of NF-kappaB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis | Q36350435 | ||
| Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha | Q36403830 | ||
| Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27. | Q36803871 | ||
| A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. | Q37421291 | ||
| Cells lacking NF-kappaB or in which NF-kappaB is not activated vary with respect to ability to sustain herpes simplex virus 1 replication and are not susceptible to apoptosis induced by a replication-incompetent mutant virus | Q37583533 | ||
| Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway | Q37683123 | ||
| Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon | Q39593618 | ||
| Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication | Q39682468 | ||
| Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo | Q39698466 | ||
| Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells | Q39753125 | ||
| An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages | Q39877213 | ||
| Activities of heterodimers composed of DNA-binding- and transactivation-deficient subunits of the herpes simplex virus regulatory protein ICP4 | Q40062603 | ||
| Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication. | Q40584504 | ||
| Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52. | Q40628193 | ||
| The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex | Q40752466 | ||
| Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation | Q40781958 | ||
| The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B. | Q40816820 | ||
| Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF-kappaB. | Q40841212 | ||
| Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis | Q40931087 | ||
| NF-kappaB activation is responsible for the synergistic effect of herpes simplex virus type 2 infection on interferon-gamma-induced nitric oxide production in macrophages | Q40994333 | ||
| Epstein-Barr virus latent membrane protein 1 activates nuclear factor-kappa B in human endothelial cells and inhibits apoptosis | Q42464747 | ||
| Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy | Q43626729 | ||
| KSHV vFLIP binds to IKK-gamma to activate IKK. | Q44532483 | ||
| Induction of RANTES/CCL5 by herpes simplex virus is regulated by nuclear factor kappa B and interferon regulatory factor 3. | Q44548916 | ||
| Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein | Q44642218 | ||
| Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus. | Q45424582 | ||
| Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor kappaB. | Q45722712 | ||
| Failure of measles virus to activate nuclear factor-kappa B in neuronal cells: implications on the immune response to viral infections in the central nervous system. | Q45750061 | ||
| Herpes simplex type 1 induction of persistent NF-kappa B nuclear translocation increases the efficiency of virus replication | Q45754258 | ||
| Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase | Q45807691 | ||
| Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination | Q50119689 | ||
| Expression of TNF-alpha by herpes simplex virus-infected macrophages is regulated by a dual mechanism: transcriptional regulation by NF-kappa B and activating transcription factor 2/Jun and translational regulation through the AU-rich region of the | Q74321530 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 5113-5124 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo | |
| P478 | volume | 80 |
| Q33743977 | Cellular transcriptome analysis reveals differential expression of pro- and antiapoptosis genes by varicella-zoster virus-infected neurons and fibroblasts |
| Q36591683 | Classical swine fever virus failed to activate nuclear factor-kappa b signaling pathway both in vitro and in vivo |
| Q34013598 | Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin |
| Q40709587 | Equine herpesvirus-1 infection disrupts interferon regulatory factor-3 (IRF-3) signaling pathways in equine endothelial cells |
| Q38843666 | Equine herpesvirus-1 suppresses type-I interferon induction in equine endothelial cells. |
| Q34581696 | Gene expression patterns in blood leukocytes discriminate patients with acute infections |
| Q41126737 | Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy |
| Q33900418 | Herpes simplex virus 1 protein kinase US3 hyperphosphorylates p65/RelA and dampens NF-κB activation. |
| Q42265673 | High frequency of varicella zoster virus reactivation associated with the use of arsenic trioxide in patients with acute promyelocytic leukemia |
| Q45411485 | Human immunodeficiency virus (HIV) type 1 Vpr induces differential regulation of T cell costimulatory molecules: direct effect of Vpr on T cell activation and immune function |
| Q92657652 | Interferon Gamma Inhibits Varicella-Zoster Virus Replication in a Cell Line-Dependent Manner |
| Q89621258 | Manipulation of the Innate Immune Response by Varicella Zoster Virus |
| Q28709497 | Modulation of NF-κB signalling by microbial pathogens |
| Q40786326 | Modulation of host CD59 expression by varicella-zoster virus in human xenografts in vivo |
| Q33791387 | Molecular mechanisms of varicella zoster virus pathogenesis |
| Q80163901 | Post varicella hepatic actinomycosis in a 5-year-old girl mimicking acute abdomen |
| Q92447215 | Pseudorabies Virus UL24 Abrogates Tumor Necrosis Factor Alpha-Induced NF-κB Activation by Degrading P65 |
| Q37534033 | RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation. |
| Q35673818 | Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis |
| Q35913878 | The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation |
| Q40038007 | The phosphorylation profile of protein kinase A substrates is modulated during Varicella-zoster virus infection |
| Q33828713 | The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3 |
| Q37606051 | Varicella zoster virus immune evasion strategies. |
| Q33828495 | Varicella-zoster virus T cell tropism and the pathogenesis of skin infection |
| Q34120083 | Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses |
| Q40073483 | Varicella-zoster virus infection induces the secretion of interleukin-8. |
| Q35665805 | Varicella-zoster virus inhibition of the NF-κB pathway during infection of human dendritic cells: role for open reading frame 61 as a modulator of NF-κB activity |
| Q36315805 | Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters |
Search more.